Atlas Trials

Targeted Treatment With Intercalated Radiotherapy in EGFR-mutant IIIA/IIIB NSCLC

Clinical trial NCT03074864 · UNKNOWN

Trial details

NCT number
NCT03074864
Sponsor
Guangdong Provincial People's Hospital
Status
UNKNOWN
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Non-small Cell Lung CancerEpidermal Growth Factor Receptor
Start date
2017-02-27
Primary completion
2019-06-30
Enrollment
90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.